Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans

Giovanna Simonetti1, Claudio Passariello, Dante Rotili

  • 1Department of Public Health Sciences, University of Rome La Sapienza, Rome Italy.

FEMS Yeast Research
|July 14, 2007
PubMed

Insights

Histone deacetylase inhibitors (HDACi) significantly reduced Candida albicans virulence factors like cell adhesion and hypha formation. This suggests HDACi could be a valuable addition to antifungal treatments for C. albicans infections.

Area of Science:

  • Microbiology
  • Epigenetics
  • Molecular Biology

Background:

  • Candida albicans utilizes virulence factors regulated by epigenetic mechanisms, such as histone acetylation/deacetylation.
  • Understanding these epigenetic controls is crucial for developing novel therapeutic strategies against C. albicans infections.

Purpose of the Study:

  • To investigate the impact of various histone deacetylase inhibitors (HDACi) on C. albicans virulence phenotypes.
  • To assess the effects of HDACi on fungal adhesion and the yeast-to-hypha transition.

Main Methods:

  • Treatment of C. albicans with selected HDAC inhibitors.
  • Assay of fungal adherence to human pneumocytes.
  • Measurement of serum-induced yeast germination.
  • Quantitative analysis of EFG1 gene transcription.
  • Testing of an HDA1-deficient C. albicans strain.

Main Results:

  • Certain HDAC inhibitors reduced C. albicans adherence to human pneumocytes by up to 90%.
  • HDAC inhibitors significantly inhibited serum-induced germination, correlating with reduced EFG1 transcription.
  • Inhibition of germination was less pronounced in an HDA1-deficient strain.

Conclusions:

  • Specific HDAC inhibitors demonstrate potential in reducing C. albicans virulence.
  • HDAC inhibitors may offer a viable therapeutic approach for managing C. albicans infections, particularly in combination therapies for at-risk patients.

Related Concept Videos

Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...